Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 15/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 15/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 15/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 13/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 12/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 12/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 12/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 12/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 12/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 12/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 12/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4632718 | 0.94 | ALOX5 (0.43) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL4633387 | 0.90 | MEN1 (0.43) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL4738463 | 0.88 | ITGB2 (0.51) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL4738079 | 0.88 | ITGB2 (0.51) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL4632709 | 0.87 | HDAC3 (0.45) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL4633744 | 0.86 | MMP2 (0.45) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL5149268 | 0.85 | CDK4 (0.46) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL4737016 | 0.85 | ALOX5 (0.48) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL14069723 | 0.84 | ALOX5 (0.45) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL14557741 | 0.83 | HPGDS (0.46) | HDAC3HDAC1HDAC2HDAC6HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080221195-A1 | 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS | BAYER SCHERING PHARMA AG (DE) | 2008-09-11 | — | — | US | claimed |
| WO-2008071453-A1 | 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-06-19 | — | — | WO | claimed |
| EP-1932831-A1 | 1,2-Diarylacetylene Derivatives of Acyltryptophanols | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-06-18 | — | — | EP | claimed |
| US-20080221195-A1 | 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS | BAYER SCHERING PHARMA AG (DE) | 2008-09-11 | — | — | US | disclosed |
| US-20080221195-A1 | 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS | BAYER SCHERING PHARMA AG (DE) | 2008-09-11 | — | — | US | disclosed |
| US-20080221195-A1 | 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS | BAYER SCHERING PHARMA AG (DE) | 2008-09-11 | — | — | US | disclosed |
| EP-1932831-A1 | 1,2-Diarylacetylene Derivatives of Acyltryptophanols | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221195-A1 | 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS | FSHR, GNRHR, TPH1 | HDAC3 1526/4885HDAC1 1780/4885HDAC2 1007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.